#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver transplant rejection PIK3CA related overgrowth spectrum Arteriosclerosis Marfan's syndrome Duchenne muscular dystrophy Factor IX deficiency Mucopolysaccharidosis II Haematological malignancy Stress cardiomyopathy Ependymoma Polycythaemia vera Bronchiolitis Kidney transplant rejection Ocular lymphoma Breast cancer metastatic More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Treatment Paroxysmal nocturnal haemoglobinuria – Basic Information Shprintzen-Goldberg syndrome – Life with Disease Pleural mesothelioma malignant – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Gaucher’s disease type III Basal cell naevus syndrome – Basic Information Alveolar rhabdomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Caba-201 Menotrophin Lolium Perenne Ascorbic Acid Bp Eclitasertib Aliskiren [18F]Mc225 GS-1720 Ethambutol Aficamten Abatacept Imlifidase Rusfertide Azd8630 IBUZATRELVIR Avacincaptad Pegol Glenzocimab Rosuvastatin Levobupivacaine ANXV More therapies…

    Learn about Your Condition

    Nasal sinus cancer Dystonic tremor Glaucoma Depression Mucosal inflammation Mental disorder Knee arthroplasty Arteriosclerosis Rectosigmoid cancer Langerhans' cell histiocytosis Gingival bleeding Uveal melanoma Eyelid ptosis Alcoholism Bronchiolitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie…

Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie

Ul. Jagiellonska Nr 78, Olsztyn, 10-357, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Amivantamab
    • Lazertinib
    • Osimertinib
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dextrose Bp
    • Tremelimumab
    • Durvalumab
    Belgium Czechia Germany Italy The Netherlands Poland +1

  • Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Lurbinectedin
    • Atezolizumab
    Belgium Germany Greece Hungary Italy Poland +1

  • Study on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 mutant non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Pembrolizumab
    Austria Belgium Denmark France Germany Italy +3

  • Study on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Nalbuphine Hydrochloride
    Germany Italy The Netherlands Poland Spain

  • Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Cisplatin
    Belgium Denmark France Germany Italy The Netherlands +3

  • Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer
    Investigated Drugs:
    • Crizotinib
    • Repotrectinib
    Austria France Germany Greece Hungary Italy +4

  • Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Glatiramer Acetate
    • Carboplatin
    • Cisplatin
    France Hungary Poland Romania Spain

  • Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Trilaciclib Dihydrochloride Dihydrate
    • Glucose Monohydrate
    • Sodium Chloride
    Austria Belgium Bulgaria Germany Greece Hungary +2

  • Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    • Dostarlimab
    • Pembrolizumab
    Belgium Bulgaria Croatia Czechia Estonia Finland +14
Previous Page
1 … 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!